Placental pathology in women with HIV.
Anti-Retroviral Agents
/ adverse effects
Chorioamnionitis
/ etiology
Female
Fetal Development
/ drug effects
Fetal Diseases
/ etiology
HIV Infections
/ complications
Humans
Infant, Newborn
Inflammation
/ etiology
Placenta
/ blood supply
Placental Insufficiency
/ etiology
Pregnancy
Pregnancy Complications, Infectious
/ pathology
Pregnancy Outcome
Premature Birth
/ etiology
Antiretroviral
Chorioamnionitis
HIV
Inflammation
Malperfusion
Pathology
Placenta
Journal
Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
03
05
2021
revised:
03
08
2021
accepted:
09
09
2021
pubmed:
20
9
2021
medline:
5
3
2022
entrez:
19
9
2021
Statut:
ppublish
Résumé
Recognizing the importance of placental features and their unique functions can provide insight into maternal health, the uterine environment during the course of pregnancy, birth outcomes and neonatal health. In the context of HIV and antiretroviral therapy (ART), there have been great strides in the prevention of mother to child transmission of HIV. However, there is still paucity of data on the impact of HIV/ART exposure on placental pathology and studies available only examine specific patterns of placental injury, further justifying the need for a more defined and comprehensive approach to the differential diagnoses of HIV/ART-exposed placentae. The purpose of this review is to consolidate findings from individual studies that have been reported on patterns of placental injury in the context of HIV/ART exposure. In both the pre- and post-ART eras HIV and/or ART has been associated with placental injury including maternal vascular malperfusion as well as acute and chronic inflammation. These patterns of injury are further associated with adverse birth outcomes including preterm birth and current evidence suggests an association between poor placental function and compromised fetal development. With the ever increasing number of pregnant women with HIV on ART, there is a compelling need for full incorporation of placental diagnoses into obstetric disease classification. It is also important to take into account key elements of maternal clinical history. Lastly, there is a need to standardize the reporting of placental pathology in order to glean additional insight into the elucidation of HIV/ART associated placental injury.
Identifiants
pubmed: 34537469
pii: S0143-4004(21)00585-3
doi: 10.1016/j.placenta.2021.09.006
pii:
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-36Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.